These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 104149)

  • 1. Amino acid and hormonal response to long-term nocturnal nasogastric feeding therapy of glycogen storage disease type I (GSD-I).
    Slonim AE; Terry A; Greene HL; Lacy WW; Burr IM
    Monogr Hum Genet; 1978; 9():37-41. PubMed ID: 104149
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycogen storage disease type I: effect of continuous nocturnal nasogastric feeding.
    Davidson AG; Wong LT; Kirby L; Tze WJ; Rigg JM; Applegarth DA
    Monogr Hum Genet; 1978; 9():29-36. PubMed ID: 104148
    [No Abstract]   [Full Text] [Related]  

  • 3. Nocturnal intragastric therapy in type I glycogen storage disease: effect on hormonal and amino acid metabolism.
    Slonim AE; Lacy WW; Terry A; Greene HL; Burr IM
    Metabolism; 1979 Jul; 28(7):707-15. PubMed ID: 286865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.
    Slonim AE; Coleman RA; Moses S; Bashan N; Shipp E; Mushlin P
    Metabolism; 1983 Jan; 32(1):70-4. PubMed ID: 6336817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional goals in glycogen storage disease.
    Williams JC
    N Engl J Med; 1986 Mar; 314(11):709-10. PubMed ID: 3081808
    [No Abstract]   [Full Text] [Related]  

  • 6. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin, glucagon and growth hormone responses during glucose, arginine and insulin tolerance tests in children with hyperthyroidism].
    Kato T; Matsuura N; Fujita H; Fujieda K; Nohara Y; Mikami Y; Abe K; Fukushima N
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):665-76. PubMed ID: 3902521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Home treatment of type I glycogenosis by continuous nocturnal gastric feeding].
    Chouraqui JP; Leluyer B
    Presse Med; 1986 Sep; 15(30):1405-8. PubMed ID: 2947059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I glycogen storage disease: five years of management with nocturnal intragastric feeding.
    Greene HL; Slonim AE; Burr IM; Moran JR
    J Pediatr; 1980 Mar; 96(3 Pt 2):590-5. PubMed ID: 6767011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and glucagon secretion in hepatic glycogenoses.
    Okada S; Seino Y; Kodama H; Yutaka T; Inui K; Ishida M; Yabuuchi H; Seino Y
    Acta Paediatr Scand; 1979 Sep; 68(5):735-8. PubMed ID: 294125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of glycogen storage diseases].
    Endres WT
    Padiatr Padol; 1991; 26(1):19-24. PubMed ID: 1905390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion in type I glycogen storage disease.
    Lockwood DH; Merimee TJ; Edgar PJ; Greene ML; Fujimoto WY; Seegmiller JE; Howell RR
    Diabetes; 1969 Nov; 18(11):755-8. PubMed ID: 5259818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Inherit Metab Dis; 1994; 17(2):234-41. PubMed ID: 7967479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal rate of enteral glucose administration in children with glycogen storage disease type I.
    Schwenk WF; Haymond MW
    N Engl J Med; 1986 Mar; 314(11):682-5. PubMed ID: 3081806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin, growth hormone, and glucagon in prediabetes mellitus--a review.
    Johansen K; Soeldner JS; Gleason RE
    Metabolism; 1974 Dec; 23(12):1185-99. PubMed ID: 4610319
    [No Abstract]   [Full Text] [Related]  

  • 20. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
    Stanley CA; Mills JL; Baker L
    Pediatr Res; 1981 Dec; 15(12):1504-8. PubMed ID: 6798537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.